Skip to main content

Peer Review reports

From: Protocol of OGSG 1901: a phase II trial of ramucirumab plus irinotecan for patients with early relapsed gastric cancer during or after adjuvant docetaxel plus S − 1 therapy

Original Submission
13 Apr 2021 Submitted Original manuscript
5 Aug 2021 Reviewed Reviewer Report
20 Apr 2022 Reviewed Reviewer Report
9 May 2022 Author responded Author comments - Toshifumi Yamaguchi
Resubmission - Version 2
9 May 2022 Submitted Manuscript version 2
18 Jun 2022 Author responded Author comments - Toshifumi Yamaguchi
Resubmission - Version 3
18 Jun 2022 Submitted Manuscript version 3
27 Jun 2022 Author responded Author comments - Toshifumi Yamaguchi
Resubmission - Version 4
27 Jun 2022 Submitted Manuscript version 4
Publishing
1 Jul 2022 Editorially accepted
15 Jul 2022 Article published 10.1186/s12885-022-09844-2

You can find further information about peer review here.

Back to article page